CLINICAL HANDBOOK OF SCHIZOPHRENIA

54 I. CORE SCIENCE AND BACKGROUND INFORMATIONREFERENCES AND RECOMMENDED READINGSDavis K. L., Stewart D. G., Friedman, J. I., Buchsbaum, M., Harvey, P. D., Hof, P. R., et al. (2003).White, matter changes in schizophrenia: Evidence for myelin-related dysfunction. Archives ofGeneral Psychiatry, 60(5), 443–456.du Bois, T. M., Deng, C., & Huang, X. F. (2005). Membrane phospholipid composition, alterations inneurotransmitter systems and schizophrenia. Progress in Neuropsychopharmacology and BiologicalPsychiatry, 29(6), 878–888.Frith, C. (2005). The neural basis of hallucinations and delusions. Comptes Rendus Biologies, 328(2),169–175.Harrison, P. J. (1999). The neuropathology of schizophrenia: A critical review of the data and their interpretation.Brain, 122(4), 593–624.Hemsley, D. R. (2005). The development of a cognitive model of schizophrenia: Placing it in context.Neuroscience and Biobehavioral Reviews, 29(6), 977–988.Konradi, C. (2005). Gene expression microarray studies in polygenic psychiatric disorders: Applicationsand data analysis. Brain Research Reviews, 50(1), 142–155.Kubicki, M., McCarley, R., Westin C. F., Park, H.J., Maier, S., Kikinis, R., et al. (2005). A review ofdiffusion tensor imaging studies in schizophrenia. Journal of Psychiatric Research, 41, 15–30.Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001). A review of MRI findings inschizophrenia. Schizophrenia Research, 49(1–2), 1–52.Shoval, G., & Weizman, A. (2005). The possible role of neurotrophins in the pathogenesis and therapyof schizophrenia. European Neuropsychopharmacology, 15(3), 319–329.van den Buuse, M., Garner, B., Gogos, A., & Kusljic, S. (2005). Importance of animal models inschizophrenia research. Australian and New Zealand Journal of Psychiatry, 39(7), 550–557.